Moderna Competitors and Similar CompaniesClear all
Celyad's competitors and similar companies include Sarepta Therapeutics.
 Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. |  Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases. | |
Founding Date | Founding Date 2007 | Founding Date 1980 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations Cambridge, US HQ Dublin, IE Zug, CH Providence, US |
Employees | Employees 17 | Employees 1,31413% increase |
Valuation ($) | Valuation ($) 11.8 m | Valuation ($) 12.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) €102k (FY, 2023) | Revenue (est.) $1.9b (FY, 2024) |
Net income | Net income (€8.4m) (FY, 2023) | Net income $235.2m (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Sarepta Therapeutics
HQ
Cambridge, US
Employees
1,314↑ 13% increase
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
View company